RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph Bavaria, MD
Organizational Affiliation: Hospital of the University of Pennsylvania
Principal Investigator - Lars Svensson, MD, PhD
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Southern California
Los Angeles, California, United States
- University of Florida - Shands Hospital
Gainesville, Florida, United States
- University of Maryland, Baltimore
Baltimore, Maryland, United States
- Columbia University Medical Center-Ny Presbyterian Hospital
New York, New York, United States
- Weill Cornell - Nyc
New York, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Pinnacle Health
Mechanicsburg, Pennsylvania, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine - St. Luke'S Hospital
Houston, Texas, United States
- the Heart Hospital of Baylor Plano
Plano, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Nov 2018
- Primary completion
- 13 Feb 2024
- Completion
- 13 Feb 2024
- Last update posted
- 9 May 2024
- Registered enrollment
- 110
- Registry id
- NCT03680040
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.